BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND CD79B, ENSG00000007312, 974, P40259, IGB, B29 AND Treatment
36 results:

  • 1. Tyrosine kinase inhibitors, immune checkpoint inhibitors combined with hepatic arterial infusion of oxaliplatin and raltitrexed versus oxaliplatin, 5-fluorouracil and leucovorin for intermediate and advanced hepatocellular carcinoma: A retrospective study.
    Zang M; Hu X; Yuan G; Li R; Li W; Pang H; Li Q; Chen J
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111019. PubMed ID: 37879230
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Efficacy and safety of Xiao-ai-ping injection add-on therapy to chemotherapy in patients with non-small cell lung cancer: A systematic review and meta-analysis.
    Li A; Liu S; Zhang H; Lin M; Guo L; Yuan C; Li Z; Xu J; Wang T
    Medicine (Baltimore); 2023 Oct; 102(40):e35483. PubMed ID: 37800773
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Evaluation of total tumor volume reduction ratio in initially unresectable colorectal liver metastases after first-line systemic treatment.
    He J; Li W; Zhou J; Sun H; Zhou C; Liu Y; Quan T; Fan W; Pan Z; Lin J; Peng J
    Eur J Radiol; 2023 Aug; 165():110950. PubMed ID: 37437437
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification and validation of a plasma metabolomics-based model for risk stratification of intrahepatic cholangiocarcinoma.
    Tan J; Shu M; Liao J; Liang R; Liu S; Kuang M; Peng S; Xiao H; Zhou Q
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12365-12377. PubMed ID: 37436513
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Construction and validation of a nomogram for hepatocellular carcinoma patients based on HCC-GRIm score.
    Yu X; Yang R; He Z; Li K; Zeng P
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12013-12024. PubMed ID: 37421461
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: a multicenter retrospective study.
    Meng Q; Zhao J; Yu Y; Wang K; Ren J; Xu C; Wang Y; Wang G
    BMC Cancer; 2023 Feb; 23(1):191. PubMed ID: 36849918
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Cost-utility analysis of atezolizumab with bevacizumab in untreated unresectable or advanced hepatocellular carcinoma in France.
    Gaugain L; Cawston H; Dubois de Gennes C; Sanchez Alvares J; Nahon P; Mazaleyrat B; Le Dissez C
    PLoS One; 2023; 18(1):e0280442. PubMed ID: 36652428
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Meta-learning algorithm development to predict outcomes in patients with hepatitis C virus-related hepatocellular carcinoma.
    Lithy RM; Omar Abdelaziz A; Awad A; Ibrahim Shousha H; Omran D; Mahmoud Nabil M; Hosni Abdelmaksoud A; Mahmoud Elbaz T; Mabrouk M
    Arab J Gastroenterol; 2022 Nov; 23(4):230-234. PubMed ID: 36400702
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Machine learning predicts the prognosis of breast cancer patients with initial bone metastases.
    Li C; Liu M; Li J; Wang W; Feng C; Cai Y; Wu F; Zhao X; Du C; Zhang Y; Wang Y; Zhang S; Qu J
    Front Public Health; 2022; 10():1003976. PubMed ID: 36225783
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Active breathing control guided stereotactic body ablative radiotherapy for management of liver metastases from colorectal cancer.
    Gamsiz H; Sager O; Uysal B; Dincoglan F; Demiral S; Colak O; Ozcan F; Dirican B; Beyzadeoglu M
    Acta Gastroenterol Belg; 2022; 85(3):469-475. PubMed ID: 35770280
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Lung Dose Measured on Postradioembolization
    Stella M; van Rooij R; Lam MGEH; de Jong HWAM; Braat AJAT
    J Nucl Med; 2022 Jul; 63(7):1075-1080. PubMed ID: 34772794
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Recent updates on Wnt signaling modulators: a patent review (2014-2020).
    Goswami VG; Patel BD
    Expert Opin Ther Pat; 2021 Nov; 31(11):1009-1043. PubMed ID: 34128760
    [No Abstract]    [Full Text] [Related]  

  • 13. Children's Hepatic Tumors International Collaboration-Hepatoblastoma Stratification (CHIC-HS) System for Pediatric Patients with Hepatoblastoma: A Retrospective, Hospital-Based Cohort Study in South Korea.
    Kim PH; Shin HJ; Yoon HM; Choi YH; Namgoong JM; Kim DY; Koh KN; Lee MJ; Yoon H; Lyu CJ; Han JW; Hahn SM; Cho YA
    Cancer Res Treat; 2022 Jan; 54(1):253-258. PubMed ID: 33781052
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Rethinking prognostic factors in locally advanced or metastatic urothelial carcinoma in the immune checkpoint blockade era: a multicenter retrospective study.
    Ruiz-Bañobre J; Molina-Díaz A; Fernández-Calvo O; Fernández-Núñez N; Medina-Colmenero A; Santomé L; Lázaro-Quintela M; Mateos-González M; García-Cid N; López-López R; Vázquez S; Anido-Herranz U
    ESMO Open; 2021 Apr; 6(2):100090. PubMed ID: 33740735
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study.
    Cortellini A; Cannita K; Tiseo M; Cortinovis DL; Aerts JGJV; Baldessari C; Giusti R; Ferrara MG; D'Argento E; Grossi F; Guida A; Berardi R; Morabito A; Genova C; Antonuzzo L; Mazzoni F; De Toma A; Signorelli D; Gelibter A; Targato G; Rastelli F; Chiari R; Rocco D; Gori S; De Tursi M; Mansueto G; Zoratto F; Filetti M; Bracarda S; Citarella F; Russano M; Cantini L; Nigro O; Buti S; Minuti G; Landi L; Ricciardi S; Migliorino MR; Natalizio S; Simona C; De Filippis M; Metro G; Adamo V; Russo A; Spinelli GP; Di Maio M; Banna GL; Friedlaender A; Addeo A; Pinato DJ; Ficorella C; Porzio G
    Eur J Cancer; 2021 May; 148():24-35. PubMed ID: 33721704
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognostic value of metastatic pattern in colorectal cancer: a multicenter retrospective analysis in a real-life cohort.
    Rumpold H; Kirchweger P; Niedersüß-Beke D; Falch D; Wundsam H; Metz-Gercek S; Piringer G; Thaler J
    Acta Oncol; 2021 Feb; 60(2):180-186. PubMed ID: 33095652
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Expert radiologist review at a hepatobiliary multidisciplinary tumor board: impact on patient management.
    Chung R; Rosenkrantz AB; Shanbhogue KP
    Abdom Radiol (NY); 2020 Nov; 45(11):3800-3808. PubMed ID: 32444889
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A Meta-analysis of TAE/TACE Versus Emergency Surgery in the treatment of Ruptured HCC.
    Xu X; Chen C; Liu Q; Huang X
    Cardiovasc Intervent Radiol; 2020 Sep; 43(9):1263-1276. PubMed ID: 32440961
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Surgical Choice for Different Types of Gallbladder Adenomyomatosis: An Initial Experience of 20 Years Laparoscopic Cholecystectomy.
    Pang L; Wu S; Kong J
    Surg Laparosc Endosc Percutan Tech; 2020 Apr; 30(2):151-155. PubMed ID: 32108730
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Novel treatment of refractory / recurrent pulmonary hepatoblastoma.
    Zhang YT; Chang J; Yao YM; Li YN; Zhong XD; Liu ZL
    Pediatr Int; 2020 Mar; 62(3):324-329. PubMed ID: 31885124
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.